IL6 and COVID-19: Although the cellular source of these cytokines was not determined during many virus infections (e.g., the cellular source of elevated IL-6 in COVID-19 patients [155]), the synergic action of these proinflammatory cytokines may inhibit lymphopoiesis in the bone marrow.